Literature DB >> 18338225

Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening.

Jui-Hua Hsieh1, Xiang S Wang, Denise Teotico, Alexander Golbraikh, Alexander Tropsha.   

Abstract

The use of inaccurate scoring functions in docking algorithms may result in the selection of compounds with high predicted binding affinity that nevertheless are known experimentally not to bind to the target receptor. Such falsely predicted binders have been termed 'binding decoys'. We posed a question as to whether true binders and decoys could be distinguished based only on their structural chemical descriptors using approaches commonly used in ligand based drug design. We have applied the k-Nearest Neighbor (kNN) classification QSAR approach to a dataset of compounds characterized as binders or binding decoys of AmpC beta-lactamase. Models were subjected to rigorous internal and external validation as part of our standard workflow and a special QSAR modeling scheme was employed that took into account the imbalanced ratio of inhibitors to non-binders (1:4) in this dataset. 342 predictive models were obtained with correct classification rate (CCR) for both training and test sets as high as 0.90 or higher. The prediction accuracy was as high as 100% (CCR = 1.00) for the external validation set composed of 10 compounds (5 true binders and 5 decoys) selected randomly from the original dataset. For an additional external set of 50 known non-binders, we have achieved the CCR of 0.87 using very conservative model applicability domain threshold. The validated binary kNN QSAR models were further employed for mining the NCGC AmpC screening dataset (69653 compounds). The consensus prediction of 64 compounds identified as screening hits in the AmpC PubChem assay disagreed with their annotation in PubChem but was in agreement with the results of secondary assays. At the same time, 15 compounds were identified as potential binders contrary to their annotation in PubChem. Five of them were tested experimentally and showed inhibitory activities in millimolar range with the highest binding constant K(i) of 135 microM. Our studies suggest that validated QSAR models could complement structure based docking and scoring approaches in identifying promising hits by virtual screening of molecular libraries.

Mesh:

Substances:

Year:  2008        PMID: 18338225     DOI: 10.1007/s10822-008-9199-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  39 in total

1.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.

Authors:  P S Charifson; J J Corkery; M A Murcko; W P Walters
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

2.  Novel variable selection quantitative structure--property relationship approach based on the k-nearest-neighbor principle

Authors: 
Journal:  J Chem Inf Comput Sci       Date:  2000-01

Review 3.  High-throughput crystallography to enhance drug discovery.

Authors:  Andrew Sharff; Harren Jhoti
Journal:  Curr Opin Chem Biol       Date:  2003-06       Impact factor: 8.822

4.  Rational selection of training and test sets for the development of validated QSAR models.

Authors:  Alexander Golbraikh; Min Shen; Zhiyan Xiao; Yun-De Xiao; Kuo-Hsiung Lee; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

5.  Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.

Authors:  Min Shen; Cécile Béguin; Alexander Golbraikh; James P Stables; Harold Kohn; Alexander Tropsha
Journal:  J Med Chem       Date:  2004-04-22       Impact factor: 7.446

6.  Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.

Authors:  Myungsok Oh; Isak Im; Yong Jae Lee; Young Hoon Kim; Jeong Hyeok Yoon; Hye Gyeong Park; Shigeki Higashiyama; Yong-Chul Kim; Woo Jin Park
Journal:  Bioorg Med Chem Lett       Date:  2004-12-20       Impact factor: 2.823

7.  Structure-based virtual screening: an application to human topoisomerase II alpha.

Authors:  Serge Christmann-Franck; Hugues-Olivier Bertrand; Anne Goupil-Lamy; P Arsène der Garabedian; Olivier Mauffret; Rémy Hoffmann; Serge Fermandjian
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

8.  Decoys for docking.

Authors:  Alan P Graves; Ruth Brenk; Brian K Shoichet
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

9.  Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.

Authors:  Yuan Zhou; Hui Peng; Qing Ji; Jing Qi; Zhenping Zhu; Chunzheng Yang
Journal:  Bioorg Med Chem Lett       Date:  2006-09-18       Impact factor: 2.823

10.  Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases.

Authors:  Liqin Zhao; Roberta D Brinton
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

View more
  6 in total

1.  An Aggregation Advisor for Ligand Discovery.

Authors:  John J Irwin; Da Duan; Hayarpi Torosyan; Allison K Doak; Kristin T Ziebart; Teague Sterling; Gurgen Tumanian; Brian K Shoichet
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

2.  Discovery of Natural Product-Derived 5-HT1A Receptor Binders by Cheminfomatics Modeling of Known Binders, High Throughput Screening and Experimental Validation.

Authors:  Man Luo; Terry-Elinor Reid; Xiang Simon Wang
Journal:  Comb Chem High Throughput Screen       Date:  2015       Impact factor: 1.339

3.  A novel method for mining highly imbalanced high-throughput screening data in PubChem.

Authors:  Qingliang Li; Yanli Wang; Stephen H Bryant
Journal:  Bioinformatics       Date:  2009-10-13       Impact factor: 6.937

4.  Estimation of the applicability domain of kernel-based machine learning models for virtual screening.

Authors:  Nikolas Fechner; Andreas Jahn; Georg Hinselmann; Andreas Zell
Journal:  J Cheminform       Date:  2010-03-11       Impact factor: 5.514

Review 5.  Getting the most out of PubChem for virtual screening.

Authors:  Sunghwan Kim
Journal:  Expert Opin Drug Discov       Date:  2016-08-05       Impact factor: 6.098

6.  Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation.

Authors:  Yuri K Peterson; Xiang S Wang; Patrick J Casey; Alexander Tropsha
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.